[Terbinafine (Lamisil)].
Breton
M C
MC
D000284:Administration, Oral; D000287:Administration, Topical; D000935:Antifungal Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D003881:Dermatomycoses / Q000188:drug therapy; D006801:Humans; D009281:Naphthalenes / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D014009:Onychomycosis / Q000188:drug therapy; D000077291:Terbinafine; D014005:Tinea / Q000188:drug therapy; D014008:Tinea Pedis / Q000188:drug therapy
D000935:Antifungal Agents; D009281:Naphthalenes; D000077291:Terbinafine
Le point sur la terbinafine (Lamisil md).